Results 131 to 140 of about 82,493 (288)
RBD Paper 2018-4-30 Supplementary
RBD Paper 2018-4-30 ...
Seyed-Mohammad Fereshtehnejad (532457) +11 more
core +1 more source
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease
Abstract Background Continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) provides 24‐h delivery of levodopa‐carbidopa prodrugs for advanced Parkinson's disease. Real‐world 1‐year European data remain limited. Objectives To characterize 1‐year changes in motor, non‐motor, autonomic, quality‐of‐life and sleep outcomes, and in concomitant therapy ...
Mario Hero +5 more
wiley +1 more source
Differential diagnosis of RBD symptomatology (idiopathic RBD or RBD mimics)
Masayuki Miyamoto, Tomoyuki Miyamoto
openaire +2 more sources
JAK2 Variant and Parkinsonian Syndromes: Coincidence or Pathophysiological Link?
Abstract Background JAK2 variants are a hallmark of myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia. These disorders are often associated with thrombotic and inflammatory complications. From a movement disorder perspective, chorea is a rare but well‐recognized neurological occurrence in this context ...
Elena Ardila Jurado +5 more
wiley +1 more source
Abstract Background Parkinson's disease (PD) and multiple system atrophy (MSA) are α‐synucleinopathies with overlapping autonomic and sleep dysfunction, but distinct trajectories. Objectives This study compared sleep and autonomic profiles in PD and MSA and elucidated disease‐specific associations using structural equation modeling (SEM).
Bora Jin +5 more
wiley +1 more source
A Multimodal Nomogram Predicting the Risk of Cognitive Impairment in Parkinson Disease
Abstract Background Cognitive impairment is the most consequential non‐motor complication of Parkinson's disease (PD), yet no validated tool integrates multimodal data to predict individualized risk trajectories. Objectives The aim is to develop and internally validate a time‐to‐event nomogram for predicting 5‐year risk of cognitive impairment in PD ...
Ahmed Negida
wiley +1 more source
Genome-wide association study of REM sleep behavior disorder in Parkinson’s disease
REM sleep behavior disorder (RBD), is a prodromal synucleinopathy affecting a subset of Parkinson’s disease (PD) patients and associated with neuropsychiatric symptoms. This study compared the genetic profiles of 13,020 PD patients with probable RBD (PD +
Yuri L. Sosero +32 more
doaj +1 more source
Background/Objectives: SARS-CoV-2 vaccine candidates comprising the receptor binding domain (RBD) of the spike protein have been shown to confer protection against infection.
Johnathan D. Guest +15 more
doaj +1 more source
Wearable Evidence Linking Dyskinesia Burden to Sleep Quality in Parkinson's Disease
Abstract Background Sleep disturbances affect 60–80% of people with Parkinson's disease (PD) and worsen quality of life. Dyskinesia is a common complication of dopaminergic therapy, yet its link to sleep quality is poorly understood. Objectives To examine whether clinician‐rated and objectively measured dyskinesia are associated with sleep quality in ...
Viktoria Azoidou +13 more
wiley +1 more source

